Survivin is upregulated in myeloma cell lines cocultured with mesenchymal stem cells

Leukemia Research

Volumn 34, Issue 10, 2010, Pages 1325-1329

  Wang, Xiaofang ^a   Zhang, Zhiqing ^b   Yao, Cheng ^c  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b Dalian Central Hospital   (China)

^c JILIN UNIVERSITY   (China)

Author keywords

Antisense oligonucleotides; Apoptosis; Drug resistance; MSCs; Survivin

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; BETA ACTIN; DAUNORUBICIN; MESSENGER RNA; PROTEIN BAX; PROTEIN BCL 2; SURVIVIN; X LINKED INHIBITOR OF APOPTOSIS;

ADIPOCYTE; APOPTOSIS; ARTICLE; CANCER RESISTANCE; CELL CONTACT; CELL DIFFERENTIATION; CELL FUNCTION; CELL SURVIVAL; COCULTURE; CONTROLLED STUDY; DRUG CYTOTOXICITY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; MESENCHYMAL STEM CELL; MULTIPLE MYELOMA; MYELOMA CELL; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

APOPTOSIS; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL LINE, TUMOR; COCULTURE TECHNIQUES; HUMANS; MESENCHYMAL STEM CELLS; MICROTUBULE-ASSOCIATED PROTEINS; MULTIPLE MYELOMA; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; UP-REGULATION;

EID: 77955980391     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2010.05.006     Document Type: Article

References (15)

1. Teicher B.A., Herman T.S., Holden S.A., et al. Tumor resistance to alkylating agents conferred by mechanisms operative only in vivo. Science 1990, 247:1457-1460.
2. Matsunaga T., Takemoto N., Sato T., et al. Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia. Nat Med 2003, 9:1158-1165.
3. Hazlehurst L.A., Valkov N., Wisner L., Storey J.A., Boulware D., Sullivan D.M. Reduction in drug-induced DNA double-strand breaks associated with beta1 integrin-mediated adhesion correlates with drug resistance in U937 cells. Blood 2001, 98:1897-1903.
4. Pittenger M.F., Mackay A.M., Beck S.C., et al. Multilineage potential of adult mesenchymal stem cells. Science 1999, 284:143-147.
5. Prockop D.J. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997, 276:71-74.
6. Silva W.A., Covas D.T., Panepucci R.A., et al. The profile of gene expression of human marrow mesenchymal stem cells. Stem Cells 2003, 21:661-669.
7. Gunn W.G., Conley A., Deininger L., Olson S.D., Prockop D.J., Gregory C.A. A crosstalk between myeloma cells and marrow stromal cells stimulates production of DKK1 and interleukin-6: a potential role in the development of lytic bone disease and tumor progression in multiple myeloma. Stem Cells 2006, 24:986-991.
8. Isolation and characterization of mesenchymal stem cells derived from bone marrow of patients with Parkinson's disease. In Vitro Cell Dev Biol-Anim 2008, 44:169-177.
9. Nefedova Y., Landowski T.H., Dalton W.S. Bone marrow stromal-derived soluble factors and direct cell contact contribute to de novo drug resistance of myeloma cells by distinct mechanisms. Leukemia 2003, 17:1175-1182.
10. Konopleva M., Konoplev S., Hu W., Zaritskey A.Y., Afanasiev B.V., Andreeff M. Stromal cells prevent apoptosis of AML cells by up-regulation of anti-apoptotic proteins. Leukemia 2002, 16:1713-1724.
11. Ambrosini G., Adida C., Sirugo G., Altieri D.C. Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting. J Biol Chem 1998, 273:11177-11182.
12. Monzo M., Rosell R., Felip E., Astudillo J., Sanchez J.J., Maestre J., et al. A novel anti-apoptosis gene: re-expression of survivin messenger RNA as a prognostic marker in non-small cell lung cancers. J Clin Oncol 1999, 17:2100-2104.
13. Kawasaki H., Altieri D.C., Lu C.-D., Toyoda M., Tenjo T., Tanigawa N. Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. Cancer Res 1999, 58:5071-5074.
14. Nakagawara A. Molecular basis of spontaneous regression of neuroblastoma: role of neurotrophic signals and genetic abnormalities. Hum Cell 1998, 11:115-124.
15. Grossman D., McNiff J.M., Li F., Altieri D.C. Expression of the apoptosis inhibitor, survivin, in nonmelanoma skin cancer and gene targeting in a keratinocyte cell line. Lab Invest 1999, 79:1121-1126.